I agree that this site is using cookies. You can find further informations here.
X
Lin, Yingtao
152  results:
Search for persons X
?
1

Comparative cost-effectiveness of first-line pembrolizumab ..:

Lin, Ying-tao ; Wang, Chang ; He, Xiao-yan..
Frontiers in Immunology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Evaluating the impact of PD-1 inhibitor treatment on key he..:

Zhang, Pei ; Zhang, Lingli ; Xu, Kai...
International Journal of Clinical Pharmacy.  46 (2024)  2 - p. 429-438 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Cost-effectiveness of utidelone and capecitabine versus mon..:

Chen, Mulan ; Zhang, Heng ; He, Xiaoyan.
Frontiers in Pharmacology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Economic evaluation of camrelizumab plus rivoceranib versus..:

Wei, Jingxuan ; Xu, Kai ; Lin, Yingtao...
International Journal of Clinical Pharmacy.  , 2024
Link: https://doi.org/10.1007/..
 
?
5

Cost-effectiveness analysis of serplulimab in combination w..:

Lin, Ying-Tao ; Zhou, Chong-Chong ; Xu, Kai..
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
6

Cost-Effectiveness Analysis of Tislelizumab Plus Chemothera..:

Zhou, Chongchong ; Wei, Jingxuan ; Xu, Kai...
Risk Management and Healthcare Policy.  16 (2023)  - p. 2447-2458 , 2023
Link: https://doi.org/10.2147/..
 
?
7

Prognostic value of apparent diffusion coefficient in neuro..:

Chen, Jian ; Ma, Ning ; Sun, Mingyao...
PeerJ.  11 (2023)  - p. e15084 , 2023
Link: https://doi.org/10.7717/..
 
?
8

How National Health Insurance Coverage Policy Affected the ..:

Shang, Linlin ; Lin, Yingtao ; Fang, Wenqing...
Risk Management and Healthcare Policy.  16 (2023)  - p. 1739-1753 , 2023
Link: https://doi.org/10.2147/..
 
?
9

Cost-effectiveness analysis of toripalimab plus chemotherap..:

Zhang, Mengdie ; Xu, Kai ; Lin, Yingtao...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

Path of integration of psychological education and ideologi..:

Lin, Yingtao
Applied Mathematics and Nonlinear Sciences.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.2478/..
 
?
11

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxe..:

Lin, Ying-tao ; Liu, Tian-xiu ; Chen, Jian..
Frontiers in Public Health.  10 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Cost-Effectiveness Analysis of Camrelizumab Immunotherapy v..:

Lin, Ying-Tao ; Chen, Ying ; Liu, Tian-Xiu..
Cancer Management and Research.  13 (2021)  - p. 8219-8230 , 2021
Link: https://doi.org/10.2147/..
 
?
13

Comparative cost-effectiveness of first-line pembrolizumab ..:

Lin, Ying-tao ; Wang, Chang ; He, Xiao-yan..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10808689/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
14

How National Health Insurance Coverage Policy Affected the ..:

Shang, Linlin ; Lin, Yingtao ; Fang, Wenqing...
info:eu-repo/semantics/altIdentifier/doi/10.2147/RMHP.S420899.  , 2023
Link: https://www.dovepress.co..
 
?
15

Cost-effectiveness analysis of toripalimab plus chemotherap..:

Zhang, Mengdie ; Xu, Kai ; Lin, Yingtao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258326/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15